Merck Punches Back In Fosamax Case

Law360, New York (July 10, 2007, 12:00 AM EDT) -- Facing thousands of product liability suits over Fosamax, Merck has fired back in court papers and formally rejected allegations that the osteoporosis drug leads to the painful deterioration of the jaw.

On Monday, Merck's attorneys submitted a formal answer and affirmative defense on behalf of the pharmaceutical giant, denying the accusations currently flying in the U.S. District Court for the Southern District of New York.

“Merck denies each and every allegation in Paragraph 18, except that it admits that Merck manufactured, marketed, and distributed the prescription...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.